Drug application
APRESAZIDE (HYDRALAZINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE)
Drugs@FDA ANDA 084735 · NOVARTIS
Key facts
| Drug name | APRESAZIDE |
|---|---|
| Active ingredients | HYDRALAZINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE |
| Application type | ANDA |
| Application number | 084735 |
| Company | NOVARTIS |
| Dosage forms | CAPSULE, ORAL |
| Strength | 25MG;25MG |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission status date | May 26, 1976 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.